pyronaridine has been researched along with Hepatitis C in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amanlou, M; Hosseini, FS | 1 |
1 other study(ies) available for pyronaridine and Hepatitis C
| Article | Year |
|---|---|
Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study.
Topics: Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; Cysteine Endopeptidases; Drug Repositioning; Hepacivirus; Hepatitis C; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Naphthyridines; Pandemics; Pneumonia, Viral; Protease Inhibitors; SARS-CoV-2; Serine Proteases; Simeprevir; Small Molecule Libraries; Viral Nonstructural Proteins | 2020 |